BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10989630)

  • 21. Getting quality and cost to the top of the agenda.
    Byrnes J; Fifer J
    Physician Exec; 2010; 36(4):22-8. PubMed ID: 20704082
    [No Abstract]   [Full Text] [Related]  

  • 22. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to "access to cervical cancer screening: training internists so skill limitations are not a barrier to care".
    Savard M
    J Womens Health (Larchmt); 2007 Apr; 16(3):429. PubMed ID: 17439388
    [No Abstract]   [Full Text] [Related]  

  • 24. Report of a national workshop on screening for cancer of the cervix.
    Rasaiah B
    CMAJ; 1992 Apr; 146(8):1279-80; author reply 1280, 1284-5. PubMed ID: 1622496
    [No Abstract]   [Full Text] [Related]  

  • 25. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 27. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
    Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
    Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer screening and the role of the physician.
    Schultz R
    J Med Assoc Ga; 1994 Apr; 83(4):199-200. PubMed ID: 8006545
    [No Abstract]   [Full Text] [Related]  

  • 30. Cervical cancer screening programs in Latin America and the Caribbean.
    Murillo R; Almonte M; Pereira A; Ferrer E; Gamboa OA; Jerónimo J; Lazcano-Ponce E
    Vaccine; 2008 Aug; 26 Suppl 11():L37-48. PubMed ID: 18945401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report of a national workshop on screening for cancer of the cervix.
    Anderson GH
    CMAJ; 1992 Apr; 146(8):1280; author reply 1280, 1284-5. PubMed ID: 1555154
    [No Abstract]   [Full Text] [Related]  

  • 32. Quality assessment of cervical screening: a population-based case-control study in the C te-D'Or region, France.
    Chaplain G; Quantin C; Brunet-Lecomte P; Mottot C; Michiels-Marzais D; Sasco AJ
    Cancer Detect Prev; 2001; 25(1):40-7. PubMed ID: 11270420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.
    Arbyn M; Herbert A; Schenck U; Nieminen P; Jordan J; Mcgoogan E; Patnick J; Bergeron C; Baldauf JJ; Klinkhamer P; Bulten J; Martin-Hirsch P
    Cytopathology; 2007 Jun; 18(3):133-9. PubMed ID: 17573762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 36. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State of the Art Symposium: prescreening and rescreening.
    O'Leary TJ
    Cancer; 2004 Dec; 102(6):331-3. PubMed ID: 15540232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening.
    Zapka JG; Taplin SH; Solberg LI; Manos MM
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):4-13. PubMed ID: 12540497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alliance for cervical cancer prevention: setting the record straight.
    Sherris J; Wright TC; Denny L; Sankaranarayanan R; Pollack AE; Sanghvi H; Sellors JW
    Am J Public Health; 2007 Feb; 97(2):200-1; author reply 201-202. PubMed ID: 17194847
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.